Istiilrlo di Ric,c~rc,lrc, I.itr~nucolo,qicl~c~ ",llurio A'qri. " 2015 7 .\lr/un. Iicrlr ABSTRACT. We assessed the protective effects of I.-propionylcarnitine, a liposoluble analogue of carnitine, in the isolated heart from rats of different ages subjected to global ischemia and reperfusion. Hearts from neonatal (3-to 7-d-old), immature (2-to 3-wk-old), and adult rats were retrogradely perfused with a modified Krebs bicarbonate buffer and subjected to ischemia and reperfusion. I.-Propionylcarnitine was given either before ischemia and throughout reperfusion (protocol 1) or during reperfusion only (protocol 2). Coronary flow, heart rate, left ventricular developed pressure, and left ventricular end-diastolic pressure were measured throughout the perfusion period. Ventricular arrhythmias and creatine kinase leakage were measured at the time of reperfusion. Postischemic recovery of coronary flow and left ventricular developed pressure were age dependent and were not affected by L-propionylcarnitine, but recovery of heart rate was decreased in neonatal and immature hearts by M and 10-% ( p < 0.05), compared with controls (protocol 2). L-Propionylcarnitine always reduced creatine kinase leakage in the adult ( p < 0.05) compared with controls (protocol I). No effects on creatine kinase leakage were observed in neonatal and immature hearts. This study found that injury induced by ischemia and reperfusion was age dependent. Neonatal and immature hearts were more resistant to injury than adult hearts. The recovery of cardiac function was not affected by 1,-propionylcarnitine. However, in the adult rat hearts, L-propionylcarnitine given before ischemia and throughout reperfusion was protective by reducing creatine kinase leakage. (Pediatr Res 34: 465-470, 1993) 13). Therefore. the aim of the present study was to assess the age response of L-propionylcarnitine on the consequences of ischemia and reperfusion in the isolated rat heart also in view of the fact that myocardial carnitine content decreases after myocardial ischemia (14) and the immature heart possesses a lower content of carnitine compared with the adult heart (1 5). On mitochondria membranes (I0) and to with and without I.-propionylcarnitine (L-PC) and subjected to global improve the postischemic recovery of myocardial function by a ischemia and reperfusion, reduction of oxidative stress due to oxygen-derived free radicals (4). Reactive oxygen intermediates are produced immediately Table 1 . Escllrsion criteria* upon reperfusion (1 1) when readmission of oxygen occurs.
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MATERIALS AND METHODS

Animals. Adult male and pregnant
-
The neonatal heart is believed to be more susceptible than the H R LVDP adult heart to the damaging effects of reperfusion as a conse- NIH Publication No. 86-23, revised 1986) .
Surgical Preparafion and Perjiusion Technique. Neonatal hearts. Male rats 3-7 d old were anesthetized with diethyl ether and 50 IU sodium heparin was administered intrahepatically. After the induction of whole-body hypothermia [by partial immersion of the animal in cold (4°C) perfusion fluid for 1 min], the chest wall was removed and the thoracic cavity filled with cold perfusion fluid (4°C). The pulmonary artery was incised near its origin, the left atrium was removed, and the aorta was cannulated in situ with a blunted 20-gauge needle. The heart was then excised, mounted on the perfusion apparatus via the aortic
cannula, and installed in a temperature-controlled chamber at 37°C.
Immatur~) and adult hearts. Immature (2-to 3-wk-old) and adult (2-to 3-mo-old) male rats were anesthetized with diethyl ether and 100 IU sodium heparin was administered intrahepatically in the first group and into a peripheral vein in the latter group. Thirty s later, hearts were excised and placed in cold (4°C) perfusion buffer until contraction ceased (approximately 15 s). Each heart was then cannulated through the aorta.
Pegusion procedures. Perfusion was camed out in the Langendorff mode at a constant pressure. Perfusion pressure was set at 60 cm Hz0 (neonatal hearts), 80 cm Hz0 (immature hearts), or 100 cm H 2 0 (adult hearts). These values were selected to correspond with the in vivo mean arterial blood pressure in rats of the various age groups ( 16).
Perfusion was with a bicarbonate buffer solution containing (in mM): NaCl 118. + 64 mm Hg (68 2 9 kPa)], and pH (7.4 2 0.02) were periodically measured with a gas analyzer and found constant throughout the experiment.
After 5 min, an intraventricular balloon was introduced into the left ventricle through the mitral valve. The ultrathin balloon was constructed to match the internal dimensions of the left ventricle ( I 7). The balloon was filled with saline and attached to a pressure transducer through a saline-filled rigid cannula. Using a microsyringe attached to a side arm of the transducer, the volume of the balloon was adjusted to give a left ventricular enddiastolic pressure of 2-8 mm Hg. After 20 min of control perfusion with bicarbonate buffer, values for cardiac function were recorded. Hearts that satisfied predefined exclusion criteria were then assigned to protocol 1 or protocol 2.
Experimental Protocol. There are several analogues of carnitine, and L-propionylcarnitine was chosen for these studies because it promptly enters the myocyte because of its high liposolubility (4, 6). We did not investigate the effects of the propionyl moiety in controls, because previous studies have shown that propionic acid given to isolated hearts was devoid of any effect on cardiac function and antioxidant enzyme (4). Therefore, in this study, control hearts were perfused with oxygenated bicarbonate buffer. Two treatment protocols were used. represented schematically in Figure 1 .
Protocol I: L-propionylcarnitine given before ischemia and throughout reperfusion. After 20 min of control perfusion, neonatal, immature, and adult hearts (n = 5-6 per group) were perfused for 15 min with either normal bicarbonate buffer (control group) or buffer containing L-propionylcarnitine M). Hearts from adult rats were also perfused with M and M of L-propionylcarnitine. Values for cardiac function were recorded at the end of the 15-min perfusion period to detect any cardiac effect of the drug. Each heart was then subjected to 30 rnin (adult heart) or 60 min (neonatal and immature heart) of normothermic global ischemia. Reperfusion was carried out with normal bicarbonate buffer (control group) or with buffer containing the same concentrations of L-propionylcarnitine as before ischemia.
Protocol 2: L-propionylcarnitine given during reperfusion only. After 20 min of control perfusion, the hearts from neonatal, immature, and adult rats (n = 5-6 per group) were subjected to 30 min (adult heart) or 60 min (neonatal and immature heart) of normothermic global ischemia. Reperfusion was performed with normal bicarbonate buffer (control group), with buffer containing M and lo-' M L-propionylcarnitine (neonatal and immature heart), or with lo-' M L-propionylcarnitine (neonatal, immature, and adult heart).
The duration of ischemia was selected to achieve approximately 50% recovery of contractile function in each age group. This was expected on the basis of pilot studies. A recovery of 50% in controls allows scope for the detection of deterioration or protection of contractile function, whichever should occur.
Esclltsion Criteria. Predefined exclusion criteria were applied before the start ofthe study and after 20 min ofcontrol perfusion. The minimal acceptable values for coronary flow, heart rate, and left ventricular developed pressure in the neonatal, immature, and adult heart are listed in Table I . Any heart that was excluded was immediately replaced by another. In the course of the study, 24% of the hearts studied were excluded.
Variables Measlrred. Left ventricular systolic and end-diastolic pressures were obtained from high-speed recordings (25 mm/s) of the pressure trace and left ventricular developed pressure was calculated as the difference between these two values (COUPSYS R-04, Experimetria, Hungary). All signals were stored for further analysis on magnetic tape (model 14 1 Racal recorder, UK). Heart rate was also derived from the pressure trace and coronary flow was measured by direct timed collection of coronary emuent. Incidence, magnitude, time to onset, and time to peak ischemiainduced conticture were also recorded. coronary flow, heart rate, and left ventricular developed pressure were measured throughout the perfusion period. Left ventricular end-diastolic pressure and creatine kinase leakage were measured throughout reperfusion. Reperfusion-induced arrhythmias were classified according to the Lambeth Convention (18). Conventional electrodes could not be used for electrographic recordings because the neonatal and immature rat hearts were too small. It was not possible to distinguish between sinus bradycardia and atrioventricular block. However, it was possible to detect ventricular arrhythmias (tachycardia, fibrillation, and premature beats) from the pressure tracing. The incidence of ventricular tachycardia and ventricular fibrillation were recorded. Creatine kinase levels in the coronary emuent were measured by a CK-NAC activated Monotest kit (Boehringer Mannheim, Mannheim, Germany) and with a spectrophotometer (DU-65 Beckman). 
RESULTS
Basal characteristics and function. Body weight, ventricular
weight, and preischemic cardiac function for each group are shown in Table 2 . As expected, body weight, ventricular weight, coronary flow, and left ventricular developed pressure increased with age. Heart rate was lower in the neonatal heart than in the immature and the adult heart. Ventricular weight to body weight ratio decreased with increasing age. However, coronary flow normalized per g of tissue was different in the three age groups. Coronary flow, heart rate, and left ventricular developed pressure measured before and after administration of L-propionylcarnitine were not affected by the drug. Stability during perjiusion and time-matched controls. Contractile function in the isolated neonatal rat heart declines in a time-dependent manner (19). This contrasts with the adult heart preparation, in which contractility is stable for long periods of perfusion. To assess age-dependent changes in stability during aerobic perfusion, hearts ( n = 6) from neonatal, immature, and adult rats were subjected to 50 min of continuous aerobic perfusion at 37°C (equivalent to the 20-min control perfusion plus the 30-min reperfusion). In the neonatal hearts coronary flow, heart rate, and left ventricular developed pressure, respectively, decreased by 7, 36, and 19%, and in the immature hearts, by 17, 4, and 16%. Therefore, data from these hearts were used to normalize ischemia/reperfusion data, whereas recovery of the adult heart was not corrected, for the reason mentioned above. Post ischemic recoverj3 uf jirnction. Postischemic recovery of coronary flow, heart rate, and left ventricular developed pressure are shown in Table 3 and Figure 2 . The immature heart was the most resistant to ischemia-and reperfusion-induced injury. as shown by the highest cardiac function recovery values: the adult heart was the least resistant. Recovery of coronary flow was not affected by L-propionylcarnitine (Table 3) . Heart rate was significantly decreased in the neonatal and the immature heart by Lpropionylcarnitine at concentrations of M and M.
respectively (protocol 2). L-Propionylcarnitine did not significantly affect the recovery of contractile function under any of the conditions. Ischemia-induced contractlire, postischemic diastolic state, and creatine kinase leakage. Table 4 summarizes other indices of ischemia-and reperfusion-induced injuries. The neonatal rat heart was significantly more resistant than the adult heart to ischemia-induced contracture, as shown by the late onset and the lower peak ofcontracture. The immature heart showed values between those of the neonatal and adult heart. Ischemia-induced contracture was not affected by L-propionylcarnitine except for the neonatal heart, where L-propionylcarnitine at a concentration of M significantly increased this variable compared with control (protocol 2) (Table 4) .
Creatine kinase leakage in each group is shown in Figure 3 . Age-dependent creatine kinase leakage (IU) in the coronary emuent persisted even after normalization (IU/g). In the adult heart. L-propionylcarnitine significantly reduced creatine kinase leakage in the coronary emuent (protocol 1) compared with control. Neonatal and immature heart were unaffected.
Left ventricular end-diastolic pressure (mm Hg) during reperfusion increased with age, but the age-dependent increase disappeared after normalization (as percent of preischemic left ventricular developed pressure) ( Table 4) . Independently of Lpropionylcarnitine, left ventricular end-diastolic pressure significantly increased after reperfusion compared with preischemic values (set between 2 and 8 mm Hg in each heart). In the adult heart, left ventricular end-diastolic pressure was significantly increased by L-propionylcarnitine at the concentration of M (protocol I). Reperfusion-induced arrhythmias. Ventricular tachycardia and ventricular fibrillation were observed at the time of reperfusion only in the adult heart. In immature and in neonatal hearts, only premature ventricular contractions were observed. The incidence of ventricular arrhythmias in the adult rat hearts was not modified by L-propionylcarnitine, whereas the incidence of ventricular fibrillation was reduced from 43 to 20% at the concentration of M (protocol I ) and from 67 to 33% at 1 0 -M (protocol 2). Correlation herween indices. We examined the relationship between recovery of contractile function and other indices of injury such as ischemia-induced contracture, left ventricular enddiastolic pressure, and creatine kinase leakage. Recovery of left ventricular developed pressure correlated poorly with creatine kinase leakage, which was also independent from the postischemic recovery of coronary flow ( p = NS). Postischemic recovery of left ventricular developed pressure correlated with left ventricular end-diastolic pressure (Fig. 4) , and a significant correlation was seen with values for the adult heart (r' = 0.848) and the immature heart (r' = 0.643) but not with the neonatal heart (r' = 0.014). Postischemic recovery of left ventricular developed pressure did not correlate with ischemia-induced contracture. nor did ischemia-induced contracture and left ventricular enddiastolic pressure.
DISCUSSION
Several studies have shown that hearts reperfused after myocardial ischemia exhibit irreversible cell injury or transient injury (stunning) by mechanisms in part attributable to the action of toxic oxygen-derived free radicals (20. 21). and it has been demonstrated that a variety of interventions with an ability to prevent free radical formation or scavenge hydroxyl radicals once formed may enhance recovery of contractile function and reduce loss of intracellular enzymes (22). This study was designed to characterize the protective effects of L-propionylcarnitine on ischemia-and reperfusion-induced injury mediated by oxygen free radicals in the isolated immature heart.
Carnitine is essential for normal fatty acid oxidation and myocardial energy production (23, 24). The neonatal capacity to oxidize long-chain fatty acid, carnitine myocardial content ( I 5). and mitochondria1 enzyme activities is lower compared with the adult heart (25. 26). Although under normal conditions FFA metabolism is not essential in the immature heart, because of a high glycolytic capacity, it should be remembered that global ischemia (zero flow ischemia) depresses the anaerobic glycolytic pathway (27). Thus, instead of simply using neonates, we compared three age groups-neonate. immature, and adult-and instead of simply supplying carnitine in its more soluble form (as I.-propionylcarnitine) at the optimal concentration for adults. we used different doses. In addition. we used multiple indices to assess tissue injury and sought to correct functional results for the natural time-dependent deterioration of any isolated organ preparation by expressing recoveries in relation to time-matched aerobic controls.
Erects of L-propion~~lcarnitin~~ on indices o f cardiuc,/itnc.tion o f ischemic/reperfirsed hear[. Although our results do not support
the view that L-propionylcarnitine improves the postischemic recovery of cardiac function, a number of important points need to be addressed.
The effects of carnitine and its derivatives on the ischemic heart are controversial. A number of studies have reported a protective effect of carnitine or its analogues (1-8, 28. 29) . Others, however, have found no such effect (9. 30, 3 1). Liedtke et a/. (2) . using intact regionally ischemic swine hearts, found that infusion of L-carnitine did not improve the global and regional parameters of mechanical cardiac function. However. when the mechanical data for performance were expressed as a function of metabolic energy expenditure. L-carnitine significantly enhanced the mechanical efficiency of the heart compared with D-carnitine.
Ferrari et a/. (4) . using isolated rabbit hearts subjected to lowflow global ischemia (60 min), found that L-propionylcarnitine lo-' M, infused throughout ischemia and reperfusion, significantly enhanced the postischemic recovery of left ventricular developed pressure from 17% (controls) to 38%. Because release
